UNSPSC 85813310: Introduction of oxazolidinones into skin and mucous membranes, external approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of oxazolidinones into skin and mucous membranes, external approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E00X28

UNSPSC 85813310 Introduction of oxazolidinones into skin and mucous membranes, external approach is a Commodity code that shows minimal alignment between its clinical taxonomy designation and actual state and local procurement activity. The recent opportunities block contains no solicitations for oxazolidinone pharmaceuticals or topical antimicrobial preparations; instead, the tagged records reflect virtual urgent care services, medical services delivery, PACE operations, occupational health screening, cancer registry management, retinal imaging devices, emergency medical technician staffing, employee health clinics, mental health and substance use treatment, medical directorships, and wellness platforms—none of which involve the application of oxazolidinone compounds to skin or mucous membranes.

The code's narrow pharmaceutical scope does not match the behavioral health, emergency medical response, occupational medicine, and integrated care services dominating the recent activity set. State and local procurement under this code designation appears dormant or mislabeled; no issuing body has posted a solicitation for topical or external antimicrobial pharmaceutical products or services in the timeframe covered by the opportunities block. Vendors pursuing state and local opportunities under this code should verify tagging accuracy with issuing bodies, as the code's therapeutic intent does not reflect current buying patterns in the dataset.